TCH346

TCH346 is a drug currently in clinical trials that is used to help treat Amyotrophic Lateral Sclerosis (ALS). Though this drug is still in testing, it is felt to be a work in progres, and it is widely thought that it will be a great advancement in medical sciences.

External Reference

 * Neurological Institute of New York Columbia University
 * National Center for Biotechnology Information article